[ARS] ENDRA Life Sciences Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

10/28/2025 - 07:10 AM

Source: View Original Filing on SEC EDGAR

Endra Life Sciences Inc

NASDAQ:NDRA

NDRA Rankings

#6779 Ranked by Market Cap

N/A Ranked by Dividends

#232 Top Loser

NDRA Latest News

Feb 26, 2026

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

Dec 4, 2025

ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Nov 20, 2025

ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

Nov 17, 2025

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

Nov 13, 2025

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

NDRA Latest SEC Filings

Mar 4, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

Mar 4, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

Jan 23, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

Jan 23, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

Jan 23, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

NDRA Stock Data

Market Cap 4.00M

Float 627.50k

Industry Diagnostics & Research

Sector Electromedical & Electrotherapeutic Apparatus

Website Link

Country United States

City ANN ARBOR